A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CpG ODNs / cytosine-phosphate-guanine oligodeoxynucleotides

[Related PubMed/MEDLINE]
Total Number of Papers: 17
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CpG ODNs  (>> Co-occurring Abbreviation)
Long Form:   cytosine-phosphate-guanine oligodeoxynucleotides
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 pUC18-CpG Is an Effective Adjuvant for a Duck Tembusu Virus Inactivated Vaccine. DTMUV, HI
2019 Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment. CTLs, DCs, DOX, LMWH
2019 Magnetic-responsive and targeted cancer nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy. MINPs, MR, NIR, PA, PTT, SPIO, TNP
2019 One-Step Self-Assembly of Multifunctional DNA Nanohydrogels: An Enhanced and Harmless Strategy for Guiding Combined Antitumor Therapy. C-DNAs, DDS
2018 Cytidine-phosphate-guanosine oligodeoxynucleotides in combination with CD40 ligand decrease periodontal inflammation and alveolar bone loss in a TLR9-independent manner. CD40L, IL-10, KO, qRT-PCR, TLR9, WT
2015 A facilely controlled length, cytotoxicity, length-dependent and cell type-dependent cellular uptake of silica nanotubes and their applications in the delivery of immunostimulatory CpG oligodeoxynucleotides. SiNTs
2015 Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy. BMDCs, HA, IL-10, NPs, PLGA, PTX, Th, Th2
2014 Nanoparticles encapsulating hepatitis B virus cytosine-phosphate-guanosine induce therapeutic immunity against HBV infection. HBsAg, HBV, IFN, pDCs, TLR9
2014 Vaccination with the RSV fusion protein formulated with a combination adjuvant induces long-lasting protective immunity. RSV, TLR, TriAdj
10  2013 Effects of two different immunotherapies on triple negative breast cancer in animal model. DC/CIK, GM-CSF, TNBC
11  2012 Binding mode of CpG oligodeoxynucleotides to nanoparticles regulates bifurcated cytokine induction via Toll-like receptor 9. IFN-alpha, TLR9
12  2012 Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis. CL, s.c, SLA
13  2011 Down-regulation of ATP-binding cassette transporter G1 expression by unmethylated CpG oligodeoxynucleotides in RAW 264.7 macrophages. ABCA1, IL-1beta, PPARgamma, TNF-alpha
14  2008 TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. APCs, BM, GVHD, NK, TLR9
15  2006 Lentivirus-like particles without reverse transcriptase elicit efficient immune responses. LTRs, RT
16  2004 Impact of immunomodulatory oligodeoxynucleotides on cytokine production in the lipopolysaccharide-stimulated human whole blood model. GpC, IFN-gamma, IL, LPS
17  2004 Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity. CpG-liposomes, DCs, IFN-gamma, IL, NK, OVA, TLR9